WallStreetZenWallStreetZen

NASDAQ: ONVO
Organovo Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ONVO stock forecasts and price targets.

Forecast return on equity

Is ONVO forecast to generate an efficient return?

Company
-3,596.55%
Industry
80.01%
Market
61.99%
ONVO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ONVO forecast to generate an efficient return on assets?

Company
-340.57%
Industry
22.35%
ONVO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ONVO earnings per share forecast

What is ONVO's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$9.00
Avg 2 year Forecast
-$9.00

ONVO revenue forecast

What is ONVO's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$200.0k+63.93%
Avg 2 year Forecast
$230.0k+88.52%
ONVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ONVO revenue growth forecast

How is ONVO forecast to perform vs Biotechnology companies and vs the US market?

Company
37.3%
Industry
152.36%
Market
10.68%
ONVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ONVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ONVO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ONVO$1.75N/AN/A
ADTX$2.23N/AN/A
QLGN$3.53N/AN/A
CNSP$0.90N/AN/A
THAR$1.15$17.00+1,378.26%Strong Buy
View Top Biotech Stocks

Organovo Holdings Stock Forecast FAQ

What is ONVO's earnings growth forecast for 2026-2027?

(NASDAQ: ONVO) Organovo Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 17.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.

Organovo Holdings's earnings in 2025 is -$12,385,000.On average, 1 Wall Street analyst forecast ONVO's earnings for 2026 to be -$13,096,087, with the lowest ONVO earnings forecast at -$13,096,087, and the highest ONVO earnings forecast at -$13,096,087.

In 2027, ONVO is forecast to generate -$13,091,433 in earnings, with the lowest earnings forecast at -$13,091,433 and the highest earnings forecast at -$13,091,433.

If you're new to stock investing, here's how to buy Organovo Holdings stock.

What is ONVO's revenue growth forecast for 2026-2027?

(NASDAQ: ONVO) Organovo Holdings's forecast annual revenue growth rate of 37.3% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 152.36%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.68%.

Organovo Holdings's revenue in 2025 is $122,000.On average, 1 Wall Street analysts forecast ONVO's revenue for 2026 to be $290,908, with the lowest ONVO revenue forecast at $290,908, and the highest ONVO revenue forecast at $290,908.

In 2027, ONVO is forecast to generate $334,544 in revenue, with the lowest revenue forecast at $334,544 and the highest revenue forecast at $334,544.

What is ONVO's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: ONVO) forecast ROA is -340.57%, which is lower than the forecast US Biotechnology industry average of 22.35%.

What is ONVO's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: ONVO) Organovo Holdings's current Earnings Per Share (EPS) is -$10.20. On average, analysts forecast that ONVO's EPS will be -$9.00 for 2026, with the lowest EPS forecast at -$9.00, and the highest EPS forecast at -$9.00. In 2027, ONVO's EPS is forecast to hit -$9.00 (min: -$9.00, max: -$9.00).

What is ONVO's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: ONVO) forecast ROE is -3,596.55%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.